SE333570B - - Google Patents

Info

Publication number
SE333570B
SE333570B SE02113/68A SE211368A SE333570B SE 333570 B SE333570 B SE 333570B SE 02113/68 A SE02113/68 A SE 02113/68A SE 211368 A SE211368 A SE 211368A SE 333570 B SE333570 B SE 333570B
Authority
SE
Sweden
Application number
SE02113/68A
Inventor
P Leeming
A Cannas-Rodriguez
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE333570B publication Critical patent/SE333570B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE02113/68A 1967-02-21 1968-02-19 SE333570B (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8172/67A GB1154976A (en) 1967-02-21 1967-02-21 N-Phenyl Indoline Derivatives

Publications (1)

Publication Number Publication Date
SE333570B true SE333570B (xx) 1971-03-22

Family

ID=9847201

Family Applications (1)

Application Number Title Priority Date Filing Date
SE02113/68A SE333570B (xx) 1967-02-21 1968-02-19

Country Status (12)

Country Link
US (2) US3574232A (xx)
AT (1) AT284110B (xx)
BE (1) BE711058A (xx)
CH (1) CH530396A (xx)
DE (1) DE1695604C3 (xx)
FR (1) FR8042M (xx)
GB (1) GB1154976A (xx)
IL (1) IL29467A (xx)
MY (1) MY7300183A (xx)
NL (1) NL157011B (xx)
NO (1) NO126371B (xx)
SE (1) SE333570B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1237008A (en) * 1968-12-18 1971-06-30 Pfizer Ltd Novel indoline derivatives
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US5173489A (en) * 1986-04-10 1992-12-22 The Dupont Merck Pharmaceutical Co. α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
US5300642A (en) * 1986-04-10 1994-04-05 The Du Pont Merck Pharmaceutical Company α, α-disubstituted aromatics and heteroaromatics as cognition enhancers
US4876259A (en) * 1987-01-05 1989-10-24 E. I. Du Pont De Nemours And Company 3,3-disubstituted indolines
US4806651A (en) * 1987-10-07 1989-02-21 E. I. Du Pont De Nemours And Company Process for preparing 3,3-disubstituted indolines
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process
US5643784A (en) * 1990-12-04 1997-07-01 H, Lundbeck A/S Indan derivatives
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
JP3833532B2 (ja) * 1999-07-21 2006-10-11 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 炎症性疾患の治療において有用な小分子

Also Published As

Publication number Publication date
NL157011B (nl) 1978-06-15
IL29467A (en) 1973-01-30
NO126371B (xx) 1973-01-29
DE1695604C3 (de) 1978-06-08
GB1154976A (en) 1969-06-11
AT284110B (de) 1970-09-10
MY7300183A (en) 1973-12-31
DE1695604A1 (de) 1972-02-24
BE711058A (xx) 1968-08-20
NL6802415A (xx) 1968-08-22
CH530396A (de) 1972-11-15
US3574232A (en) 1971-04-06
US3686182A (en) 1972-08-22
DE1695604B2 (de) 1977-10-27
FR8042M (xx) 1970-08-10

Similar Documents

Publication Publication Date Title
AU5765369A (xx)
AT298283B (xx)
AU1273466A (xx)
AU2116667A (xx)
AU2256867A (xx)
BE708320A (xx)
BE426053A (xx)
AU1614766A (xx)
BE692780A (xx)
AU1763766A (xx)
AU1868267A (xx)
BE711376A (xx)
BE711138A (xx)
BE710651A (xx)
BE710459A (xx)
BE710327A (xx)
BE709854A (xx)
BE709639A (xx)
BE709410A (xx)
BE709237A (xx)
BE709172A (xx)
BE709037A (xx)
BE692778A (xx)
BE708843A (xx)
AU459699A (xx)